Treatment of the Anaemia of Chronic Renal Failure with Recombinant Human Erythropoietin

This publication has 28 references indexed in Scilit:

• Recombinant Human Erythropoietin Treatment in Pre-Dialysis Patients
  Annals of Internal Medicine, 1989
• Erythropoietin alert: risks of high hematocrit hemodialysis.
  1988
• Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells.
  Journal of Biological Chemistry, 1988
• Effect of Treatment with Recombinant Human Erythropoietin on Peripheral Hemodynamics and Oxygenation
  Published by S. Karger AG ,1987
• Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.
  BMJ, 1987
• Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias
  British Journal of Haematology, 1987
• Microcytic Anemia in Dialysis Patients: Reversible Marker of Aluminum Toxicity
  American Journal of Kidney Diseases, 1987
• EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
  The Lancet, 1986
• Characterization and Biological Effects of Recombinant Human Erythropoietin
  Immunobiology, 1986
• Cloning and expression of the human erythropoietin gene.
  Proceedings of the National Academy of Sciences, 1985